Bluejay Capex To Revenue from 2010 to 2024
| BJDX Stock | USD 3.84 0.06 1.54% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 4.33 | Current Value 3.86 | Quarterly Volatility 0.26865243 |
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
Bluejay | Capex To Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.